Product/Composition:- | Levamisole tablets |
---|---|
Strength:- | 50 mg & 150 mg |
Form:- | Tablets |
Reference Brands:- | Generic formulations |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Levamisole enhances immune response by stimulating T-cell activity and modulating immune function. It also has anthelmintic properties, targeting parasitic worms. Benefits include effective treatment of intestinal parasites, immune support in certain diseases, and potential cancer therapy adjuncts. It supports parasite eradication and immune modulation worldwide.
Levamisole tablets are approved primarily in Europe for parasitic infections and immune modulation, with limited regulatory approval in the US. Regulatory dossiers must include clinical efficacy, safety profiles, manufacturing standards, and pharmacovigilance plans. In the US, the FDA reviews quality and safety data, while the EU’s EMA oversees regional safety and quality compliance. For guidance on dossier preparation, regulatory pathways, and market entry, visit PharmaTradz. Proper adherence to regional requirements supports timely approval, safe use, and global availability, ensuring effective treatment of parasitic infections and immune-related conditions worldwide, with a focus on safety and efficacy.